» Articles » PMID: 20413639

Imaging in Radiation Oncology: a Perspective

Overview
Journal Oncologist
Specialty Oncology
Date 2010 Apr 24
PMID 20413639
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

An inherent goal of radiation therapy is to deliver enough dose to the tumor to eradicate all cancer cells or to palliate symptoms, while avoiding normal tissue injury. Imaging for cancer diagnosis, staging, treatment planning, and radiation targeting has been integrated in various ways to improve the chance of this occurring. A large spectrum of imaging strategies and technologies has evolved in parallel to advances in radiation delivery. The types of imaging can be categorized into offline imaging (outside the treatment room) and online imaging (inside the treatment room, conventionally termed image-guided radiation therapy). The direct integration of images in the radiotherapy planning process (physically or computationally) often entails trade-offs in imaging performance. Although such compromises may be acceptable given specific clinical objectives, general requirements for imaging performance are expected to increase as paradigms for radiation delivery evolve to address underlying biology and adapt to radiation responses. This paper reviews the integration of imaging and radiation oncology, and discusses challenges and opportunities for improving the practice of radiation oncology with imaging.

Citing Articles

Evaluating motion of pancreatic tumors and anatomical surrogates using cine MRI in 0.35T MRgRT under free breathing conditions.

Lewis B, Guta A, Shin J, Ji Z, Kim J, Kim T J Appl Clin Med Phys. 2023; 24(6):e13930.

PMID: 37073428 PMC: 10243312. DOI: 10.1002/acm2.13930.


MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.

Murgic J, Gregov M, Mrcela I, Budanec M, Krengli M, Frobe A Acta Clin Croat. 2023; 61(Suppl 3):65-70.

PMID: 36938552 PMC: 10022406. DOI: 10.20471/acc.2022.61.s3.9.


MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?.

Persson E, Svanberg N, Scherman J, Gustafsson C, Fridhammar A, Hjalte F Clin Transl Radiat Oncol. 2022; 38:183-187.

PMID: 36479236 PMC: 9720486. DOI: 10.1016/j.ctro.2022.11.012.


The future of MRI in radiation therapy: Challenges and opportunities for the MR community.

Goodburn R, Philippens M, Lefebvre T, Khalifa A, Bruijnen T, Freedman J Magn Reson Med. 2022; 88(6):2592-2608.

PMID: 36128894 PMC: 9529952. DOI: 10.1002/mrm.29450.


Clinical validation of a commercially available deep learning software for synthetic CT generation for brain.

Lerner M, Medin J, Gustafsson C, Alkner S, Siversson C, Olsson L Radiat Oncol. 2021; 16(1):66.

PMID: 33827619 PMC: 8025544. DOI: 10.1186/s13014-021-01794-6.


References
1.
Brock K, Dawson L, Sharpe M, Moseley D, Jaffray D . Feasibility of a novel deformable image registration technique to facilitate classification, targeting, and monitoring of tumor and normal tissue. Int J Radiat Oncol Biol Phys. 2006; 64(4):1245-54. DOI: 10.1016/j.ijrobp.2005.10.027. View

2.
Ghilezan M, Yan D, Liang J, Jaffray D, Wong J, Martinez A . Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys. 2004; 60(5):1602-10. DOI: 10.1016/j.ijrobp.2004.07.709. View

3.
Fuller D, Jin H, Koziol J, Feng A . CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Brachytherapy. 2005; 4(3):207-16. DOI: 10.1016/j.brachy.2005.07.005. View

4.
Moffat B, Chenevert T, Lawrence T, Meyer C, Johnson T, Dong Q . Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A. 2005; 102(15):5524-9. PMC: 555936. DOI: 10.1073/pnas.0501532102. View

5.
Dawson L, Eccles C, Bissonnette J, Brock K . Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys. 2005; 62(4):1247-52. DOI: 10.1016/j.ijrobp.2005.03.072. View